Literature DB >> 25230202

Olfactory Pathology in Central Nervous System Demyelinating Diseases.

Gabriele C DeLuca1, Albert Joseph2, Jithin George1, Richard L Yates1, Marie Hamard1, Monika Hofer3, Margaret M Esiri1.   

Abstract

Olfactory dysfunction is common in multiple sclerosis (MS). Olfactory bulb and tract pathology in MS and other demyelinating diseases remain unexplored. A human autopsy cohort of pathologically confirmed cases encompassing the spectrum of demyelinating disease (MS; n = 17), neuromyelitis optica [(NMO); n = 3] and acute disseminated encephalomyelitis [(ADEM); n = 7] was compared to neuroinflammatory [herpes simplex virus encephalitis (HSE); n = 3], neurodegenerative [Alzheimer's disease (AD); n = 4] and non-neurologic (n = 8) controls. For each case, olfactory bulbs and/or tracts were stained for myelin, axons and inflammation. Inferior frontal cortex and hippocampus were stained for myelin in a subset of MS and ADEM cases. Olfactory bulb/tract demyelination was frequent in all demyelinating diseases [MS 12/17 (70.6%); ADEM 3/7 (42.9%); NMO 2/3 (66.7%)] but was absent in HSE, AD and non-neurologic controls. Inflammation was greater in the demyelinating diseases compared to non-neurologic controls. Olfactory bulb/tract axonal loss was most severe in MS where it correlated significantly with the extent of demyelination (r = 0.610, P = 0.009) and parenchymal inflammation (r = 0.681, P = 0.003). The extent of olfactory bulb/tract demyelination correlated with that found in the adjacent inferior frontal cortex but not hippocampus. We provide unequivocal evidence that olfactory bulb/tract demyelination is frequent, can occur early and is highly inflammatory, and is specific to demyelinating disease.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  demyelinating disease; multiple sclerosis; neuroinflammation; olfaction; pathology

Mesh:

Year:  2014        PMID: 25230202      PMCID: PMC8029356          DOI: 10.1111/bpa.12209

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  30 in total

1.  Olfactory dysfunction in multiple sclerosis.

Authors:  R L Doty; C Li; L J Mannon; D M Yousem
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

2.  Olfactory function in patients with multiple sclerosis: a diffusion tensor imaging study.

Authors:  Katharina Erb; Georg Bohner; Lutz Harms; Oender Goektas; Franca Fleiner; Esther Dommes; Felix Alexander Schmidt; Bettina Dahlslett; Lutz Lüdemann
Journal:  J Neurol Sci       Date:  2012-02-17       Impact factor: 3.181

3.  The olfactory bulbs in Alzheimer's disease.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

4.  Absence of cortical demyelination in neuromyelitis optica.

Authors:  B F Gh Popescu; J E Parisi; J A Cabrera-Gómez; K Newell; R N Mandler; S J Pittock; V A Lennon; B G Weinshenker; C F Lucchinetti
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

5.  Olfactory dysfunction in multiple sclerosis: association with secondary progression.

Authors:  Ana Martins Silva; Ernestina Santos; Inês Moreira; Andreia Bettencourt; Ester Coutinho; Alexandra Gonçalves; Claudia Pinto; Xavier Montalban; Sara Cavaco
Journal:  Mult Scler       Date:  2011-10-21       Impact factor: 6.312

Review 6.  The olfactory vector hypothesis of neurodegenerative disease: is it viable?

Authors:  Richard L Doty
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

7.  Olfactory dysfunction in multiple sclerosis. Relation to plaque load in inferior frontal and temporal lobes.

Authors:  R L Doty; C Li; L J Mannon; D M Yousem
Journal:  Ann N Y Acad Sci       Date:  1998-11-30       Impact factor: 5.691

Review 8.  Olfactory dysfunction in Parkinson disease.

Authors:  Richard L Doty
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

9.  Multiple sclerosis associated with sinusitis: case-controlled study in general practice.

Authors:  D Gay; G Dick; G Upton
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

10.  Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.

Authors:  Gabriele C DeLuca; Rose Alterman; Jenny L Martin; Arunesh Mittal; Samkeliso Blundell; Shannon Bird; Harry Beale; Lai San Hong; Margaret M Esiri
Journal:  Brain       Date:  2013-03-12       Impact factor: 13.501

View more
  13 in total

1.  Unilateral olfactory sensitivity in multiple sclerosis.

Authors:  Kimberley P Good; Isabelle A Tourbier; Paul Moberg; Jennifer L Cuzzocreo; Rena J Geckle; David M Yousem; Dzung L Pham; Richard L Doty
Journal:  Physiol Behav       Date:  2016-10-22

2.  Olfactory dysfunction in neuromyelitis optica spectrum disorders.

Authors:  Lin-Jie Zhang; Ning Zhao; Ying Fu; Da-Qi Zhang; Jing Wang; Wen Qin; Ningnannan Zhang; Kristofer Wood; Yaou Liu; Chunshui Yu; Fu-Dong Shi; Li Yang
Journal:  J Neurol       Date:  2015-05-28       Impact factor: 4.849

3.  The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis.

Authors:  Mostafa Almasi; Mohammad Ali Sahraian; Fahimeh Haji Akhoundi; Hamid Reza Ezzati; Mohammad Rohani
Journal:  Basic Clin Neurosci       Date:  2021-01-01

4.  Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.

Authors:  James M Hillis; Julie Davies; Mayara Vieira Mundim; Osama Al-Dalahmah; Francis G Szele
Journal:  J Neuroinflammation       Date:  2016-08-22       Impact factor: 8.322

5.  Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.

Authors:  Florian Cornelius Uecker; Heidi Olze; Hagen Kunte; Christian Gerz; Önder Göktas; Lutz Harms; Felix Alexander Schmidt
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

6.  Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.

Authors:  K E Hopperton; D Mohammad; M O Trépanier; V Giuliano; R P Bazinet
Journal:  Mol Psychiatry       Date:  2017-12-12       Impact factor: 15.992

7.  Olfactory dysfunction in patients with primary progressive MS.

Authors:  Felix A Schmidt; Matthew B Maas; Rohat Geran; Charlotte Schmidt; Hagen Kunte; Klemens Ruprecht; Friedemann Paul; Önder Göktas; Lutz Harms
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-06-14

8.  Organic solvents and MS susceptibility: Interaction with MS risk HLA genes.

Authors:  Anna Karin Hedström; Ola Hössjer; Michail Katsoulis; Ingrid Kockum; Tomas Olsson; Lars Alfredsson
Journal:  Neurology       Date:  2018-07-03       Impact factor: 9.910

9.  Gene Expression Profile of Olfactory Transduction Signaling in an Animal Model of Human Multiple Sclerosis.

Authors:  Jeongtae Kim; Meejung Ahn; Yuna Choi; Poornima Ekanayake; Chul Min Park; Changjong Moon; Kyungsook Jung; Akane Tanaka; Hiroshi Matsuda; Taekyun Shin
Journal:  Exp Neurobiol       Date:  2019-02-28       Impact factor: 3.261

10.  Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.

Authors:  Rachel E James; James Hillis; István Adorján; Betty Gration; Mayara V Mundim; Asif J Iqbal; Moon-Moon Majumdar; Richard L Yates; Maureen M H Richards; Gwendolyn E Goings; Gabriele C DeLuca; David R Greaves; Stephen D Miller; Francis G Szele
Journal:  Glia       Date:  2015-09-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.